Happy weekend for the CELG holders up nice after markets congrats. See you Monday article inside expect it to be 76 Mon.
Published: Fri, 11/09/12
Friday, November 9, 5:38 PMCelgene (CELG) says Phase 3 studies
of Abraxane, a treatment for advanced pancreatic cancer, met its primary endpoint of overall survival. Based on the results, the company plans to submit applications for registration in the U.S., Europe and other markets